Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$420,999
+$70,567 QoQ
Shares Held
351
-7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#3,894
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $9,679,558 across 10 Drug Manufacturers - General names. LLY ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,904 | $4,547,078 | |
| 2 | AMGN |
Amgen Inc
|
8,954 | $3,242,422 | |
| 3 | GSK |
GSK plc
|
9,360 | $490,651 | |
| 4 | PFE |
Pfizer Inc
|
20,000 | $481,600 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
351 | $420,999 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,840 | $364,940 | |
| 7 | SNY |
Sanofi
|
1,845 | $78,707 | |
| 8 | ABBV |
AbbVie Inc.
|
114 | $28,686 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $420,999 | 351 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $350,432 | 381 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $409,453 | 381 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $290,703 | 381 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $452,127 | 580 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $499,675 | 605 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $1,181,160 | 1,530 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $1,266,894 | 1,430 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $389,313 | 430 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $334,522 | 430 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $250,655 | 430 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $230,965 | 430 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $201,661 | 430 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $147,670 | 430 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $157,311 | 430 | Shares | Sole | 2023-02-23 | |
| No filing history on record for this holder in this stock. | ||||||